✦ LIBER ✦

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

✍ Scribed by Hiromitsu Kumada; Joji Toyota; Takeshi Okanoue; Kazuaki Chayama; Hirohito Tsubouchi; Norio Hayashi

Book ID: 116652575
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 792 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2011.07.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PGI17 Cost-Effectiveness of Telaprevir W

PGI17 Cost-Effectiveness of Telaprevir With Peginterferon and Ribavirin for Treatment-Naive Patients Chronically Infected With HCV of Genotype 1 in Japan

✍ H. Ishida; S. Terai; I. Sakaida; Y. Inoue 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Determinants of response to triple thera

Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1

✍ Norio Akuta; Fumitaka Suzuki; Yuya Seko; Yusuke Kawamura; Hitomi Sezaki; Yoshiyu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

290 EARLY VIROLOGICAL RESPONSE PROFILES

290 EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILAR

✍ F. Poordad; J.G. McHutchison; M.L. Shiffman; T. Berg; A.J. Muir; M.P. Manns; A.M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 188 KB

448 RESPONSE-GUIDED THERAPY WITH BOCEPRE

448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1

✍ M.P. Manns; F. Poordad; B.R. Bacon; S. Bruno; R. Esteban; M. Silva; M. Buti; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Peginterferon alfa-2a (40 kd) and ribavi

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1

✍ Lennox J. Jeffers; William Cassidy; Charles D. Howell; Sylvia Hu; K. Rajender Re 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Black Americans (blacks) have a high prevalence of chronic hepatitis C virus (HCV) infection and respond poorly to therapy with interferon alfa-based regimens, but they have been underrepresented in clinical trials. The aim of this study was to assess the rate of sustained virological response (SVR)

Peginterferon alfa-2a (40 kd) and ribavi

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1

✍ Michal R. Pijak; Frantisek Gazdik; Stefan Hrusovsky 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

An interesting report by Streetz et al. published in HEPATOLOGY described the production of hepatocyte conditional gp130 knockout mice subjected to chronic liver injury by repeated carbon tetrachloride (CCl 4 ) treatment. 1 Chronic injury induces liver regeneration by recruitment of cells from a pre